Market closed

PMV Pharmaceuticals/$PMVP

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About PMV Pharmaceuticals

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Ticker

$PMVP

Sector

Health Care

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Princeton, United States

Employees

Website

www.pmvpharma.com

PMVP Metrics

BasicAdvanced

$72M

-

-$1.00

1.47 -

Price and volume

Market cap

$72M

Beta

1.47

52-week high

$2.26

52-week low

$1.39

Average daily volume

205K

Financial strength

Current ratio

13.981

Quick ratio

13.481

Long term debt to equity

6.076

Total debt to equity

6.704

Management effectiveness

Return on assets (TTM)

-20.27%

Return on equity (TTM)

-23.63%

Valuation

Price to book

0.36

Price to tangible book (TTM)

0.36

Price to free cash flow (TTM)

-1.506

Growth

Earnings per share change (TTM)

-35.78%

3-year earnings per share growth (CAGR)

-3.33%

What the Analysts think about PMVP

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for PMV Pharmaceuticals stock.

PMVP Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

PMVP Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PMVP

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for PMV Pharmaceuticals stock?

PMV Pharmaceuticals (PMVP) has a market cap of $72M as of January 15, 2025.

What is the P/E ratio for PMV Pharmaceuticals stock?

The price to earnings (P/E) ratio for PMV Pharmaceuticals (PMVP) stock is 0 as of January 15, 2025.

Does PMV Pharmaceuticals stock pay dividends?

No, PMV Pharmaceuticals (PMVP) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next PMV Pharmaceuticals dividend payment date?

PMV Pharmaceuticals (PMVP) stock does not pay dividends to its shareholders.

What is the beta indicator for PMV Pharmaceuticals?

PMV Pharmaceuticals (PMVP) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.